№ 6 / 2016 / 80-84

Pharmacological responses in patients with different etiology of restless legs syndrom

Author: Abramovskikh L.E.¹, Pilipenko P.I.², Vostrikova E.V.³

Abstract

The effectiveness of pharmacological responses in patients with different restless legs syndromes (RLS): idiopathic, family and neuropathic forms was evaluated. 139 patients with RLS were included into research. They were divided into 3 groups: 67 patients with family RLS, 46 patients with idiopathic RLS, and 26 patients with neuropathic RLS. All patients were administrated drugs: mirapex (pramipexol), madopar (levodopa+benserosid), benzodiazepines (lorazepam, clonazepam), opioid (tramadol), antidepressant (trittico), miorealaxant (baclofen). Medications have been taken in terns. Every two weeks one of the medications was substituted into another one. The evaluation of pharmacological response to every above mentioned drugs have been carried out according to the scale of Relative Global Assessment Scale (RGAS) two weeks later by the end of administration of each drug. The data were compared for effectiveness of the response in the comparison groups. Madopar and mirapex proved more effective than clonazepam, lorazepam tramadol within each group (p < 0,01). No significant differences in efficacy between Madopar mirapex and in the treatment of RLS has been detected (p > 0,05). Conclusion. The most effective drugs against RLS were mirapex, madopar. These drugs are the first choice in the treatment of RLS. Clonazepam, Lorazepam and tramadol were less effective. The antidepressants trittiko and miorealaksanta baclofen did not demonstrated any positive effects.

Key words

baclofen, clonazepam, lorazepam, madopar, mirapex, restless legs syndrome, tramadol, trittico

References

Aver’anov Yu.N., Podchufarova E.V. Restless legs syndrome // Nevrologicheskiy zhurnal = Neurological Journal. 1997. (3). 12-16. [In Russian]
Artem’ev D.V., Obuhova A.V. Restless legs syndrome // Nervnye bolezni = Neurological disorders. 2013. (3). 1-7. . [In Russian]
Veyn A.M., Levin Ya.I. Disturbances of sleep and wakefulness / Ed. N.N. Yahno, D.R. Shtul’man. Moscow, 2003. 422–424. . [In Russian]
Levin O.S. Restless legs syndrome (Willis – Ekbom disease). Moscow: MEDpress-inform, 2015. 24-27. . [In Russian]
Fedorova N.V. Use of mirapex in restless legs syndrome. Moscow, 2010. 18 p. . [In Russian]
Allen R.P., Picchietti D.L., Garcia-Borreguero D. et al. International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis – Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance // Sleep Med. 2014. 15. (8). 860-873.
Becker P.M., Jamieson A.O., Brown W.D. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases // Sleep. 1993. 16. (8). 713–716.
Cynthia L. Comella Treatment of Restless Legs Syndrome // Neurotherapeutics. 2014. 11. (1). 177–187.
Earley C.J. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients // Sleep. 1996. 19. (10). 801-810.
Garcia-Borreguero D., Odin P., Serrano C. Restless legs syndrome and PD: a review of the evidence for a possible association // Neurology. 2003. 61. (6). 49-55.
Garcia-Borreguero D., Kohnen R., Silber M.H. et al. The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group // Sleep Med. 2014. 15. (8). 860–873.
Happe S., Klosch G., Saletu B. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin // Neurology. 2001. 57. (9). 1717–1719.
Högl B., Comella C. Therapeutic advances in restless legs syndrome // Mov. Disord. 2015. 30. (11). 1574–1579.
Jørgensen S., Rønborg S. Restless legs syndrome //Ugeskr. Laeger. 1989. 151. (11). 670-671.
Mühlau G. Six months’ treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice // MMW Fortschr. Med. 2004. 146. (3). 87-93.
Ondo W., Jankovic J. Restless legs syndrome: Clinicoetiologic correlates // Neurology. 1996. 47. (6). 1435-1441.
Restless Legs Syndrome Foundation. URL: https://www.rls.org/ (дата обращения 06.10.2016).
Rinaldi F., Galbiati A., Marelli S. et al. Treatment options in intractable restless legs syndrome/Willis – Ekbom disease (RLS/WED) // Curr. Treat. Options Neurol. 2016. 18. (2). 7.
Saletu M., Anderer P., Saletu-Zyhlarz G. et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam // Eur. Neuropsychopharmacol. 2001. 11. (2). 153-161.
Scholz H., Trenkwalder C., Kohnen R. et al. Dopamine agonists for the treatment of restless legs syndrome // Cochrane Database Syst. Rev. 2011. 16. (3). URL: http://www.ncbi.nlm.nih.gov/pubmed/21412893 (дата обращения 06.10.2016).
Scholz H., Trenkwalder C., Kohnen R. et al. Levodopa for the treatment of restless legs syndrome. 16 February 2011. URL: https://www.ncbi.nlm.nih.gov/pubmed/21328278 (дата обращения 06.102016).
Silber M.H., Ehrenberg B.L., Allen R.P. An algorithm for the management of restless legs syndrome // Mayo Clin Proc. 2004. 79. (7). 916–922.
Stiasny K., Wetter T.C., Trenkwalder C., Oertel W.H. Restless legs syndrome and its treatment by dopamine agonists // Parkinsonism Relat. Disord. 2000. 7. (1). 21-25.
Trenkwalder C., Paulus W., Walters A.S. The restless legs syndrome // Lancet Neurol. 2005. 4. (8). 465–75.
Trenkwalder C., Stiasny-Kolster K., Kupsch A. et al. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome // Movement Disorders. 2006. 21. (9). 1404–1410.
Walker S., Fine A., Kryger M.H. Sleep complaints are common in a dialysis unit // Am. J. Kidney Dis. 1995. 26. (5). 751-756.
Willis T. The London Practice of Physick. L.: printed for Basset T., Dring T., Harper C., Crook W., 1692. URL: http://catalogue.nla.gov.au/Record/6753939 (дата обращения 06.10.2016).
Yee B., Killick R., Wong K. Restless legs syndrome // Aust. Fam. Physician. 2009. 38. (5). 296-300

About Authors (Correspondence):

Abramovskikh L.E. – postgraduate student, neurologist, е-mail: leyla.ahundova@gmail.com

Pilipenko P.I. – doctor of medical sciences, professor, head of department, е-mail: pilipen@rambler.ru

Vostrikova E.V. – candidate of medical sciences, associate professor, head of regional specialized scientific and practical neurological center, е-mail: evetansk@ya.ru

Received: 27/12/2016